Zdrowie i gospodarka · 28/06/2019
FDA Announces Draft Guidance for Heart Failure Drug Development
The FDA is releasing a draft guidance that clarifies the endpoints for drug development to treat heart failure, including the potential for approving drugs that show improvement in symptoms or physical function without a significant impact on survival or hospitalization.